THE Therapeutic Goods
Administration (TGA) has issued a
new set of cost recovery statements
relating to their activities, including
that the estimated revenue from
complementary medicines was
$11.9m in 2013-14, while expenses
were $16m, leaving a deficit of
$4.1m.
The forecast for 2014-15 was
expenses of $15.6m and revenue of
$11.6m.
Estimated application fees
amounted to $2.4m in 2013-14
and were forecast to be $1.8m in
2014-15.
For details go to www.tga.gov.au.The above article was sent to subscribers in Pharmacy Daily's issue from 21 Jul 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Jul 14
PEAK pharmacy bodies are calling on the Australian Government to extend the new Commonwealth Prac Payment to pharmacy students, citing the challenges of “placement poverty” in unpaid practical placements.
AFT Pharmaceuticals is set to develop a topical treatment for keloid and hypertrophic scarring in partnership with NZ’s Massey Ventures, the commercialisation arm of Massey University, and the Gillies McIndoe Research Institute.
THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.